Is this you? Create Your Porfile

Christopher Rowe

Commonwealth Scientific and Industrial Research Organisation

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Christopher Rowe is active.

Explore More

Publication

Featured researches published by Christopher Rowe.

Archive | 2012

Method and apparatus for the assessment of medical images

Vincent Dore; Olivier Salvado; Nicholas Dowson; Jurgen Mejan-Fripp; Christopher Rowe; Victor Villemagne; Luping Zhou

Society of Nuclear Medicine Annual Meeting Abstracts | 2006

11C-PIB PET imaging in the differential diagnosis of dementia

Victor Villemagne; Steven Ng; Sylvia Gong; Uwe Ackermann; Kerryn E. Pike; Greg Savage; William E. Klunk; Chester A. Mathis; Colin Masters; Christopher Rowe

Archive | 2009

Radiation Dosimetry of b-Amyloid Tracers 11 C-PiB and 18 F-BAY94-9172

Graeme O'Keefe; Timothy Saunder; Steven Ng; Uwe Ackerman; Henri Tochon-Danguy; J. Gordon Chan; Sylvia Gong; Thomas Dyrks; Stefanie Lindemann; Gerhard Holl; Ludger Dinkelborg; Victor Villemagne; Christopher Rowe

Archive | 2010

Molecular brain imaging in dementia

Victor Villemagne; Christopher Rowe

Progress in Biomedical Optics and Imaging - Proceedings of SPIE , 7262 (2009) | 2009

Alzheimer's disease detection using 11 C-PiB with improved partial volume effect correction

Parnesh Raniga; Pierrick Bourgeat; Jurgen Fripp; Oscar Acosta; Sebastien Ourselin; Christopher Rowe; Victor Villemagne; Olivier Salvado

Society of Nuclear Medicine Annual Meeting Abstracts | 2008

A longitudinal study of {beta}-amyloid deposition with 11C-PiB-PET

Victor Villemagne; Kerryn E. Pike; Uwe Ackermann; Gareth Jones; David Ames; Kathryn Ellis; Henri Tochon-Danguy; Graeme O'Keefe; Colin Masters; Christopher Rowe

Society of Nuclear Medicine Annual Meeting Abstracts | 2007

First results from human studies of a novel F-18 PET ligand for brain {beta}-amyloid imaging

Christopher Rowe; Steven Ng; Rachel S. Mulligan; Uwe Ackermann; William Browne; Graeme O'Keefe; Henri Tochon-Danguy; Gordon Chan; Hank Kung; Mei-Ping Kung; Daniel Skovronsky; Thomas Dyrks; Gerhard Holl; Sabine Krause; Matthias Friebe; Stefanie Lindemann; Wolf Sittner; Ludger Dinkelborg; Colin Masters; Victor Villemagne

Society of Nuclear Medicine Annual Meeting Abstracts | 2007

Galantamine improves cognitive performance without effecting nicotinic receptors in early Alzheimer's disease as measured by 2[18F]F-A-85380 PET

Julia R. Ellis; Victor Villemagne; Pradeep J. Nathan; Rachel S. Mulligan; Sylvia Gong; Graeme O'Keefe; Henri Tochon-Danguy; Keith Wesnes; Greg Savage; Christopher Rowe

Society of Nuclear Medicine Annual Meeting Abstracts | 2007

Nicotinic receptor imaging with 2-[18F]F-A-85380 PET does not differentiate early Alzheimer's disease patients from healthy controls

Julia R. Ellis; Victor Villemagne; Pradeep J. Nathan; Rachel S. Mulligan; Sylvia Gong; Clare Smith; Henri Tochon-Danguy; Greg Savage; Christopher Rowe

Alzheimers & Dementia | 2012

Rates of conversion to MCI and Alzheimer's in the Australian Imaging, Biomarkers and Lifestyle (AIBL) cohort over 36 months

K. Ellis; Paul Maruff; Ralph N. Martins; Colin L. Masters; Simon McBride; Lance Macaulay; Christopher Rowe; Stephanie R. Rainey-Smith; Alan Rembach; Greg Savage; Cassandra Szoeke; Kevin Taddei; Victor L. Villemagne; Ping Zhang; David Ames

Explore More